Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study (vol 123, pg 1039, 2023)

被引:0
|
作者
Guerzoni, Simona [1 ,2 ]
Baraldi, Carlo [3 ]
Brovia, Daria [1 ,2 ]
Cainazzo, Maria Michela [1 ,2 ]
Lo Castro, Flavia [4 ]
Pani, Luca [1 ,2 ,5 ,6 ,7 ]
机构
[1] AOU Policlin Modena, Pharmacol & Clin Metab Toxicol Headache Ctr, Digital & Predict Med, Modena, Italy
[2] AOU Policlin Modena, Dept Specialist Med, Drug Abuse Lab Clin Pharmacol & Pharmacogen, Modena, Italy
[3] Univ Modena & Reggio Emilia, PhD Sch Neurosci, Dept Biomed Metab & Neural Sci, Modena, Italy
[4] Univ Modena & Reggio Emilia, Postgrad Sch Pharmacol, Dept Biomed Metab & Neural Sci, Modena, Italy
[5] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Pharmacol Unit, Modena, Italy
[6] Univ Miami, Dept Psychiat & Behav Sci, Miami, FL USA
[7] VeraSci, Durham, NC USA
关键词
D O I
10.1007/s13760-023-02340-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:2075 / 2075
页数:1
相关论文
共 43 条
  • [11] Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
    Munoz-Vendrell, Albert
    Campoy, Sergio
    Caronna, Edoardo
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Nieves Castellanos, Candela
    Olivier, Marina
    Campdelacreu, Jaume
    Prat, Joan
    Camina Muniz, Javier
    Molina Martinez, Francisco Jose
    Minguez-Olaondo, Ane
    Ruibal Salgado, Marta
    Santos Lasaosa, Sonia
    Navarro Perez, Maria Pilar
    Morollon, Noemi
    Lopez Bravo, Alba
    Cano Sanchez, Luis Miguel
    Garcia-Sanchez, Sonia Maria
    Garcia-Ull, Jesica
    Rubio-Flores, Laura
    Gonzalez-Martinez, Alicia
    Quintas, Sonia
    Echavarria Iniguez, Ana
    Gil Luque, Sendoa
    Castro-Sanchez, Maria Victoria
    Adell Ortega, Vanesa
    Garcia Alhama, Jessica
    Berrocal-Izquierdo, Nuria
    Belvis, Robert
    Diaz-Insa, Samuel
    Pozo-Rosich, Patricia
    Huerta-Villanueva, Mariano
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [12] European multicenter study on the use of anti-CGRP monoclonal antibodies in real life for migraine prevention: study cohort description
    Caronna, Edoardo
    Jose Gallardo, Victor
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Huerta Villanueva, Mariano
    Munoz, Albert
    Campoy, Sergio
    Cuadrado Godia, Elisa
    Dorado, Laura
    Obach, Victor
    Fabregat, Neus
    Rodriguez Vico, Jaime
    Diaz de Teran, Javier
    Membrilla, Javier
    Pascual, Julio
    Garate, Gabriel
    Gago, Ana
    Guerrero, Angel
    Sanahuja, Jordi
    Sanchez Soblechero, Antonio
    Lozano Ros, Alberto
    Irimia Sieira, Pablo
    Sanchez del Rio, Margarita
    Echeverria Urabayen, Amaya
    Garcia Azorin, David
    Gonzalez Osorio, Yesica
    Gonzalez Quintanilla, Vicente
    Lopez Bravo, Alba
    Fernandez Lazaro, Iris
    Quintas Gutierrez, Sonia
    Gonzalez-Martinez, Alicia
    Flores Pina, Belen
    Manera Zorrilla-Lequerica, Paula
    Jaimes Sanchez, Alex
    Garcia Gomez, Andrea
    Alvarez Escudero, Rocio
    Oterino Duran, Agustin
    Velasco Juanes, Fernando
    Sifontes, Walter
    Rodriguez Montolio, Joana
    Nieves Castellanos, Candela
    Olivier, Marina
    Layos-Romero, Almudena
    Andres Lopez, Alberto
    Sanchez Caballero, Francisco
    Beltran Blasco, Isabel
    Millan Vazquez, Manuel
    Lamas Perez, Raquel
    Viguera Romero, Javier
    Santos-Lasaosa, Sonia
    CEPHALALGIA, 2023, 43 (1supp)
  • [13] Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
    Albert Muñoz-Vendrell
    Sergio Campoy
    Edoardo Caronna
    Alicia Alpuente
    Marta Torres-Ferrus
    Candela Nieves Castellanos
    Marina Olivier
    Jaume Campdelacreu
    Joan Prat
    Javier Camiña Muñiz
    Francisco José Molina Martínez
    Ane Mínguez-Olaondo
    Marta Ruibal Salgado
    Sonia Santos Lasaosa
    María Pilar Navarro Pérez
    Noemí Morollón
    Alba López Bravo
    Luis Miguel Cano Sánchez
    Sonia María García-Sánchez
    Jésica García-Ull
    Laura Rubio-Flores
    Alicia Gonzalez-Martinez
    Sonia Quintas
    Ana Echavarría Íñiguez
    Sendoa Gil Luque
    María Victoria Castro-Sánchez
    Vanesa Adell Ortega
    Jessica García Alhama
    Nuria Berrocal-Izquierdo
    Robert Belvís
    Samuel Díaz-Insa
    Patricia Pozo-Rosich
    Mariano Huerta-Villanueva
    The Journal of Headache and Pain, 24
  • [14] Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study
    Krymchantowski, Abouch
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    Silva-Neto, Raimundo Pereira
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 181 - 185
  • [15] Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
    Gantenbein, Andreas R.
    Agosti, Reto
    Gobbi, Claudio
    Flugel, Dominique
    Schankin, Christoph J.
    Viceic, Dragana
    Zecca, Chiara
    Pohl, Heiko
    CEPHALALGIA, 2021, 41 (11-12) : 1181 - 1186
  • [16] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Marta Torres-Ferrús
    Victor J. Gallardo
    Alicia Alpuente
    Edoardo Caronna
    Eulalia Gine-Cipres
    Patricia Pozo-Rosich
    Journal of Neurology, 2021, 268 : 3789 - 3798
  • [17] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Torres-Ferrus, Marta
    Gallardo, Victor J.
    Alpuente, Alicia
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
  • [18] Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study
    Alpuente, Alicia
    Torre-Sune, Anna
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (08)
  • [19] Sex differences in the response and tolerability to anti-CGRP monoclonal antibodies for migraine prevention in real life: results from a European multicenter observational study
    Caronna, Edoardo
    Jose Gallardo, Victor
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Huerta Villanueva, Mariano
    Munoz, Albert
    Campoy, Sergio
    Cuadrado Godia, Elisa
    Dorado, Laura
    Obach, Victor
    Fabregat, Neus
    Rodriguez Vico, Jaime
    Diaz de Teran, Javier
    Membrilla, Javier
    Pascual, Julio
    Garate, Gabriel
    Gago, Ana
    Guerrero, Angel
    Sanahuja, Jordi
    Sanchez Soblechero, Antonio
    Lozano Ros, Alberto
    Irimia Sieira, Pablo
    Sanchez del Rio, Margarita
    Echeverria Urabayen, Amaya
    Garcia Azorin, David
    Gonzalez Osorio, Yesica
    Gonzalez Quintanilla, Vicente
    Lopez Bravo, Alba
    Fernandez Lazaro, Iris
    Quintas Gutierrez, Sonia
    Flores Pina, Belen
    Manera Zorrilla-Lequerica, Paula
    Jaimes Sanchez, Alex
    Garcia Gomez, Andrea
    Gonzalez-Martinez, Alicia
    Alvarez Escudero, Rocio
    Oterino Duran, Agustin
    Velasco Juanes, Fernando
    Sifontes, Walter
    Rodriguez Montolio, Joana
    Nieves Castellanos, Candela
    Olivier, Marina
    Layos-Romero, Almudena
    Andres Lopez, Alberto
    Sanchez Caballero, Francisco
    Beltran Blasco, Isabel
    Millan Vazquez, Manuel
    Lamas Perez, Raquel
    Viguera Romero, Javier
    Santos-Lasaosa, Sonia
    CEPHALALGIA, 2023, 43 (1supp)
  • [20] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA. The RAMO study: early results
    Montisano, D. A.
    Giossi, R.
    Canella, M.
    Vernieri, F.
    Altamura, C.
    Grazzi, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25